首页> 中国专利> 组合物在制备治疗发育性视网膜血管疾病的药物中的用途

组合物在制备治疗发育性视网膜血管疾病的药物中的用途

页面导航

摘要
著录项
法律信息
相似文献

摘要

本发明公开了一种组合物用于制备治疗发育性视网膜血管疾病的药物的用途，其中该组合物包含有效剂量的金钗石斛(Dendrobium nobile Lindley)。

著录项

公开/公告号CN110538273A

专利类型发明专利
公开/公告日2019-12-06

原文格式PDF
申请/专利权人赵效明;
展开▼

申请/专利号CN201810531072.7
发明设计人赵效明;
展开▼

申请日2018-05-29
分类号
代理机构广州三环专利商标代理有限公司;
代理人郝传鑫
地址中国台湾台北市北投区石牌路二段4号4楼
入库时间 2024-02-19 14:44:26

法律信息

法律状态公告日

法律状态信息

法律状态
2019-12-31

实质审查的生效 IPC(主分类):A61K36/8984 申请日:20180529

实质审查的生效
2019-12-06

公开

公开

相似文献

专利
中文文献
外文文献

1. 组合物在制备治疗发育性视网膜血管疾病的药物中的用途 [P] . 中国专利： CN110538273A . 2019-12-06
2. 联合应用酶抑制剂及其药学组合物在制备治疗和预防动脉硬化、预防和治疗根据杰尔－库姆斯分类法分类的Ⅰ型过敏反应以及治疗和预防与毛囊和表皮角化过度和角质细胞的过度增殖相关的皮肤疾病的药物中的用途 [P] . 中国专利： CN100579582C . 2010.01.13
3. composition, pharmaceutical composition, effervescent dosage form, multiple unit oral oral pharmaceutical composition, extended release pharmaceutical dosage form, enteric coated pharmaceutical dosage form, stable pharmaceutical dosage form for oral administration to mammalian subjects, method for treating diseases acid-related diseases by inhibiting gastric acid secretion, method for treating a bacterial infection caused or caused by helicobacter pylori, process for preparing a compound of formula 3, process for preparing a compound of formula 5, use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion, use of a compound of formula 1 for the preparation of a medicament for treating a bacterial infection caused or caused by helicobacter pyl or use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion [P] . BRPI0617987A2 . 2011-08-16

机译：组合物，药物组合物，泡腾剂型，多单位口服口服药物组合物，缓释药物剂型，肠溶衣药物剂型，向哺乳动物受试者口服给药的稳定药物剂型，通过抑制胃酸治疗疾病的方法酸分泌，治疗由幽门螺杆菌引起或引起的细菌感染的方法，制备式3化合物的方法，制备式5化合物的方法，式1化合物在制备用于治疗胃的药物中的用途通过抑制胃酸分泌来治疗与酸有关的疾病，将式1的化合物用于制备用于治疗由幽门螺杆菌引起或引起的细菌感染的药物，或将式1的化合物用于制备用于治疗的药物通过抑制胃酸分泌来治疗胃酸相关疾病
4. Use of product comprising catuama extract as an antioxidant or cerebral vasodilating agent, pharmaceutical composition comprising such product for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals, method for the prophylaxis or treatment of cerebral vascular disorders and disorders caused by improper pressing of free radicals using said product and use of said product for the production of a pharmaceutical composition, for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals [P] . BR0102185A . 2003-02-18

机译：包含catuama提取物作为抗氧化剂或脑血管舒张剂的产品的用途，包含该产品的药物组合物用于预防或治疗由自由基的不当存在引起的血管疾病和病症，预防或治疗脑血管疾病和病症的方法由于使用所述产品不当按压自由基而导致的疾病，以及所述产品在制备药物组合物中的用途，所述药物组合物用于预防或治疗血管疾病和由自由基的不当存在引起的疾病
5. compound, pharmaceutical composition, method of treating a mammal suffering from a disease or condition involving monoamine reuptake or monoamine receptor-related disorder, method of treating a mammal against chemical dependence comprising co-administration of a first component and a second component, use of a compound for the preparation of a medicament for the treatment of a disease or condition involving monoamine reuptake or monoamine receptor-related disorder and use of a compound for the preparation of a medicament for the treatment of a chemical dependency [P] . BRPI0620587A2 . 2011-11-16

机译：化合物，药物组合物，治疗患有涉及单胺再摄取或单胺受体相关疾病的疾病或病症的哺乳动物的方法，针对化学依赖性治疗哺乳动物的方法，包括共同施用第一成分和第二成分，化合物，用于制备用于治疗涉及单胺再摄取或单胺受体相关疾病的疾病或病症的药物，以及该化合物在制备用于治疗化学依赖性的药物中的用途